Mainz Biomed NV (FRA:4TO) 3-Year Revenue Growth Rate : -33.90% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV 3-Year Revenue Growth Rate?

Mainz Biomed NV's Revenue per Share for the three months ended in Dec. 2024 was €0.00.

During the past 12 months, Mainz Biomed NV's average Revenue per Share Growth Rate was -58.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -33.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of Mainz Biomed NV was 16.00% per year. The lowest was -33.90% per year. And the median was 9.30% per year.

Competitive Comparison of Mainz Biomed NV's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Mainz Biomed NV's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mainz Biomed NV's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mainz Biomed NV's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Mainz Biomed NV's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Mainz Biomed NV 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Mainz Biomed NV (FRA:4TO) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Mainz Biomed NV 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (FRA:4TO) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

MYNZ:USA

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Mainz Biomed NV Headlines

No Headlines